---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-21-053303"
form_type: "8-K"
ticker: "TARA"
cik: "0001359931"
company_name: "Protara Therapeutics, Inc."
filed_at: "2021-10-18T23:59:59+00:00"
generated_at: "2026-06-28T20:14:18.386639+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Protara Therapeutics CMO Departs; Jathin Bandari Named Interim CMO

## Summary
- Martín Sebastian Olivo, M.D., left as Chief Medical Officer effective Oct 15, 2021; will serve as consultant through Nov 22, 2021.
- Jathin Bandari, M.D., promoted to VP, Head of Clinical Development and Interim Chief Medical Officer.
- Severance includes nine months base salary lump sum, pro-rata bonus, COBRA reimbursement, and pro-rata equity vesting.
- Dr. Bandari joined Protara in April 2020; is a urologic oncologist with fellowship at University of Pittsburgh Medical Center.

## SEC filing metadata
- accession: 0001213900-21-053303
- form_type: 8-K
- ticker: TARA
- cik: 0001359931
- company_name: Protara Therapeutics, Inc.
- filed_at: 2021-10-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1359931/000121390021053303/0001213900-21-053303-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1359931/000121390021053303/ea149033-8k_protarathera.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-21-053303
- JSON: https://secwatch.observer/filing/0001213900-21-053303.json
- Plain text: https://secwatch.observer/filing/0001213900-21-053303.txt

## Key facts
- Executive change
  Martín Sebastian Olivo departed as Chief Medical Officer at Protara Therapeutics, Inc..
  - Action: will no longer be employed
  - Role: Chief Medical Officer
  source text: Effective October 15, 2021, Martín Sebastian Olivo, M.D. will no longer be employed by the Company as Chief Medical Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1359931/000121390021053303/0001213900-21-053303-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.